Skip to content

SION SION Price / book

Price / book at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
5.9×-1.7×
AbbVie logo
AbbVieABBV
261×+221×
Septerna, Inc. logo
Septerna, Inc.SEPN
2.9×
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
3.3×+1.5×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

Based on the most recent quarter.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's price / book?
SION (SION) reported price / book of 6.3× in Q1 2026.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.